Skip to main content
. 2019 Aug 14;107(1):195–202. doi: 10.1002/cpt.1565

Table 2.

Initial decisions on cohort marketing applications by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA)

    Initial EMA outcome, N = 107
Approved (98) Not approved (3) Withdrawn (6)

Initial FDA outcome,

N = 107

Approved (91) 90 1 0
Not approved (14) 8 2 4
Withdrawn (2) 0 0 2

Shaded cells indicate concordant outcomes.